Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis-Reference-Cited by-同舟云学术

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis

Published:2017-09 Issue: Volume:82 Page:171-183
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ives Natalie J.^ORCID,Suciu Stefan,Eggermont Alexander M.M.,Kirkwood John,Lorigan Paul,Markovic Svetomir N.,Garbe Claus,Wheatley Keith,Bufalino Rosaria,Cameron David,Cascinelli Natale,Doherty Valerie,Eggermont Alexander,Garbe Claus,Gore Martin,Hancock Barry,Harrison Rebecca,Ives Natalie,Kirkwood John,Kressig Michael,Lee Sandra,Lorigan Paul,MacKie Rona,Markovic Svetomir N.,Marsden Jerry,Suciu Stefan,Suman Vera,Turner Lesley,Wheatley Keith

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials;Lens;J Clin Oncol,2002

2. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684;Kirkwood;J Clin Oncol,1996

3. A pooled analysis of Eastern Cooperative Oncology Group and Intergroup trials of adjuvant high-dose interferon for melanoma;Kirkwood;Clin Cancer Res,2004

4. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190;Kirkwood;J Clin Oncol,2000

5. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma;Grob;Lancet,1998

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients;Frontiers in Oncology;2024-08-01

2. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023;Scientific Reports;2024-07-12

3. Adjuvant immunotherapy for melanoma patients: progress and opportunities;ESMO Open;2024-05

4. Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale;Journal of Oncology Pharmacy Practice;2024-04-23

5. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22